Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Search Criteria
Gene/CloneSpeciesStageAnatomy ItemExperimenter
lama1xenopus stomodeal-hypophyseal primordium [+] 

Too many results?Too few results?

Experiment details for lama1

Dickinson AJ and Sive HL (2009) Assay



Gene Clone Species Stages Anatomy
lama1.S laevis NF stage 35 and 36 to NF stage 37 and 38 stomodeal-hypophyseal primordium

  Fig. 7. Laminin persists in the primary mouth region when Frzb-1/Crescent are depleted or when wnt-8 is overexpressed. Sagittal sections (anterior to the left) assayed at stage 35-37, in 2-3 independent experiments. Laminin is immunolabed green, nuclear propidium iodide, red; cement gland is outlined by a dotted gray line. Panels denoted by primes are tracings of Laminin immunolabeling (green). Bracket indicates the presumptive primary mouth; cg, cement gland. Scale bars: 170 μm. (A) Laminin persistence in frzb-1/crescent morphants is specific. (a) Control morpholino and GFP mRNA results in a normal absence of Laminin in the presumptive primary mouth (100%, n=10). (b) In frzb-1/crescent morphants (also injected with control GFP mRNA), Laminin persists in the primary mouth region (87%, n=10). Note that similar phenotypes were seen in morphants injected without GFP mRNA. (c) Control morpholino and frzb-1 mRNA (200 pg) results in a normal absence of Laminin in the presumptive primary mouth (n=10). (d) Co-injection of frzb-1/crescent morpholinos and frzb-1 mRNA restores the absence of Laminin in 70% of morphants (n=10). (B) Laminin persists in embryos locally depleted of frzb-1/crescent. (a) Schematic of the experimental design. (b) Recipients receiving tissue injected with control morpholino and GFP mRNA have a normal absence of Laminin (100%, n=7). (c) Eighty-nine percent of recipients receiving tissue from frzb-1/crescent morphants have persistent Laminin (n=9). (C) Temporal and spatial overexpression of Wnt-8 results in persistent Laminin. (a) Schematic of the experimental design. (b) Recipients receiving tissue injected with GFP::HSE have a normal absence of Laminin (91%, n=11). (c) Seventy-five percent of recipients receiving tissue from embryos injected with GFP::HSE::wnt-8 have persistent Laminin (n=12). (D) Wnt signaling regulates the expression of basement membrane components. Schematic depicts experimental design. Results are an average of two independent experiments. (a) Increased frzb-1 results in fibronectin mRNA that is 45% of the control level, laminin-γ1 mRNA that is 48% of the control level andβ 1-integrin that is 112% of the control level (n=20). (b) Temporally increased wnt-8 results in fibronectin mRNA that is 232% of the control level, laminin-γ1 mRNA that is 170% of the control level and β1-integrin mRNA that is 93% of the control levels (n=20).